The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
i mean and there are fructokinase inhibitors that are being developed pfizer has one that's now in a finish to phase two trial it was quite successful at treating fatty liver and so now they're taking that drug to phase three
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
and uh fizer actually had a success in a phase two trial where it reduced fatty liver pretty significantly and improved insulin resistance